Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus

被引：0
|
作者：
Cella, C. A. [1 ]
Spada, F. [1 ]
Galdy, S. [1 ]
Frezza, A. M. [1 ]
Catapano, M. [1 ]
Funicelli, L. [1 ]
Calleri, A. [1 ]
Zorzino, L. [1 ]
Mancuso, P. [1 ]
Radice, D. [1 ]
Fazio, N. [1 ]
机构：
[1] European Inst Oncol, Gastrintestinal Tumors & Neuroendocrine Tumors Un, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31260-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2344
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [41] Initial Treatment of Well-Differentiated Neuroendocrine Tumors
    Dasari, Arvind
    Yao, James
    ONCOLOGY-NEW YORK, 2014, 28 (11): : 945 - 947
  • [42] ISL-1 Expression is a Prognostic Marker in Patients With Well-Differentiated Pancreatic Neuroendocrine Tumors
    Assi, H.
    Hatoum, H.
    Maldonado-Vital, M.
    Fung, K. -M.
    PANCREAS, 2021, 50 (03) : 457 - 458
  • [43] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Hai-Yan Chen
    Yao Pan
    Jie-Yu Chen
    Lu-lu Liu
    Yong-Bo Yang
    Kai Li
    Ri-Sheng Yu
    Guo-Liang Shao
    European Radiology, 2022, 32 : 8317 - 8325
  • [44] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Chen, Hai-Yan
    Pan, Yao
    Chen, Jie-Yu
    Liu, Lu-lu
    Yang, Yong-Bo
    Li, Kai
    Yu, Ri-Sheng
    Shao, Guo-Liang
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8317 - 8325
  • [45] Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
    Asa, Sylvia L.
    La Rosa, Stefano
    Basturk, Olca
    Adsay, Volkan
    Minnetti, Marianna
    Grossman, Ashley B.
    ENDOCRINE PATHOLOGY, 2021, 32 (01) : 169 - 191
  • [46] Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
    Strosberg, Jonathan R.
    Fisher, George A.
    Benson, Al B.
    Anthony, Lowell B.
    Arslan, Bulent
    Gibbs, John F.
    Greeno, Edward
    Iyer, Renuka V.
    Kim, Michelle K.
    Maples, William J.
    Philip, Philip A.
    Wolin, Edward M.
    Cherepanov, Dasha
    Broder, Michael S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (08) : 2450 - 2459
  • [47] Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
    Jonathan R Strosberg
    George A Fisher
    Al B Benson
    Lowell B Anthony
    Bulent Arslan
    John F Gibbs
    Edward Greeno
    Renuka V Iyer
    Michelle K Kim
    William J Maples
    Philip A Philip
    Edward M Wolin
    Dasha Cherepanov
    Michael S Broder
    World Journal of Gastroenterology, 2015, (08) : 2450 - 2459
  • [48] Epigenetic Dysregulation of 5-hydroxymethylcytosine in Well-Differentiated Pancreatic Neuroendocrine Tumors
    Sharma, Aarti E.
    Olivas, Andrea
    Parilla, Megan
    Yassan, Lindsay
    Wang, Hanlin
    Zhang, Sharon S.
    Weber, Christopher
    Keutgen, Xavier M.
    Hart, John
    Krausz, Thomas
    Setia, Namrata
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (02) : E11 - E15
  • [49] Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
    Sylvia L. Asa
    Stefano La Rosa
    Olca Basturk
    Volkan Adsay
    Marianna Minnetti
    Ashley B. Grossman
    Endocrine Pathology, 2021, 32 : 169 - 191
  • [50] Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
    Strosberg, J.
    Al-Toubah, T.
    Morse, B.
    Haider, M.
    Valone, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 237 - 237
12345